Advertisement
Advertisement
Advertisement
Advertisement
Netflix: Ahad Raza Mir show cancelled after first season

Netflix: Ahad Raza Mir show cancelled after first season

Netflix: Ahad Raza Mir show cancelled after first season

Netflix Ahad Raza Mir show cancelled

Advertisement
  • Ahad Raza Mir is in great shape because all of his productions are very successful in Pakistan and because Netflix’s Resident Evil marked his acting debut in Hollywood.
  • After appearing in Yakeen Ka Safar as Dr. Asfandyar, Ahad developed a devoted fan base in Pakistan.
  • Netflix has canceled the sitcom after just one season, which is unfortunate for Ahad Raza Mir’s fans.
Advertisement

Ahad Raza Mir is in great shape because all of his productions are very successful in Pakistan and because Netflix’s Resident Evil marked his acting debut in Hollywood. After appearing in Yakeen Ka Safar as Dr. Asfandyar, Ahad developed a devoted fan base in Pakistan.

At least in Pakistan, he has been delivering hits after hits after hits without a single miss. When they recognized him as Arjun Batra in Resident Evil, his fans were ecstatic and warmly responded to his performance.

Netflix has canceled the sitcom after just one season, which is unfortunate for Ahad Raza Mir’s fans. The discontinuation of Resident Evil was due to the film’s failure to have the desired effect on the viewing public. Despite the fact that viewers enjoy watching Ahad on an international platform, there won’t be a season 2 of the show.

People are reacting to the show’s cancellation have a look:

Advertisement

Also Read

Ella Balinska is thankful to Ahad Raza Mir for being supportive during shoot
Ella Balinska is thankful to Ahad Raza Mir for being supportive during shoot

Ella Balinska is thankful to Ahad Raza Mir for being supportive. In...

Advertisement
Advertisement
Read More News On

Catch all the International News, Breaking News Event and Latest News Updates on The BOL News


Download The BOL News App to get the Daily News Update & Follow us on Google News.


End of Article

Next Story